Ken Dychtwald is president and CEO of Age Wave, a firm that guides companies and government groups in product/service development for baby boomers and mature adults. He has dedicated his life to battling ageist stereotypes while promoting a new, vital and purposeful role for life’s second half.

Mark McClellan is the Robert J. Margolis Professor of Business, Medicine, and Policy, and founding director of the Duke-Margolis Center for Health Policy at Duke University. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.

Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for disease as the founder and Chief Executive Officer of Medable. A Stanford-trained physician-scientist, Dr. Longmire identified critical barriers to drug development and founded Medable to pioneer a new category of clinical trial technologies that remove traditional roadblocks to participation and radically accelerate the research process.

Joseph Coughlin is founder and director of the Massachusetts Institute of Technology AgeLab. He teaches in MIT's Department of Urban Studies & Planning and the Sloan School's Advanced Management Program.

Pinchas Cohen, MD, is the dean of the USC Leonard Davis School of Gerontology at the University of Southern California.

Freda Lewis-Hall, MD, a pioneer in medicine and leadership, has been on the front lines of health care for more than 40 years as a clinician, researcher, and leader in the biopharmaceuticals and life sciences industries.

Jennie Chin Hansen is the immediate past CEO of the American Geriatrics Society. Earlier in her career, she was president of the 38 million-member AARP, a position she held during the development of the Affordable Care Act.

Dr. Angelique Chan holds joint appointments as a tenured Associate Professor in the Signature Program in Health Services & Systems Research at the Duke-NUS Medical School, and in the Department of Sociology at the National University of Singapore. She is the Inaugural Executive Director of the Centre for Ageing Research & Education at Duke-NUS.

Annalisa Jenkins, MD, is a life sciences thought leader with more than 25 years of biopharmaceutical industry experience. Jenkins served as president and CEO of Dimension Therapeutics, a leading NASDAQ-listed gene therapy company that was acquired by Ultragenyx in November 2017.

Laura Carstensen is a professor of psychology and the Fairleigh S. Dickinson Jr. professor in public policy at Stanford University, where she is the founding director of the Stanford Center on Longevity. In academia, Carstensen is known for socioemotional selectivity theory, a life-span theory of motivation.